Community hub
Recent from talks
Knowledge base stats:
Talk channels stats:
Members stats:
Public Health England
Public Health England (PHE) was an executive agency of the Department of Health and Social Care in England which began operating on 1 April 2013 to protect and improve health and wellbeing and reduce health inequalities. Its formation came as a result of the reorganisation of the National Health Service (NHS) in England outlined in the Health and Social Care Act 2012. It took on the role of the Health Protection Agency, the National Treatment Agency for Substance Misuse and a number of other health bodies. It was an executive agency of the Department of Health and Social Care, and a distinct delivery organisation with operational autonomy.
On 29 March 2021, the UK Government announced that PHE would be disbanded and that its public health functions would be transferred, in proposals to reform public health structures. From 1 October 2021, PHE's health protection functions were formally transferred into the UK Health Security Agency (UKHSA), while its health improvement functions were transferred to the Office for Health Improvement and Disparities (DHSC), NHS England, and NHS Digital.
Proposals for reorganising the National Health Service were published in the early months of the Cameron–Clegg coalition, in a July 2010 white paper from the Department of Health (under Andrew Lansley) titled "Equity and excellence: Liberating the NHS". This was followed by a more detailed paper "Healthy Lives, Healthy People: Our strategy for public health in England" in November.
The bill to implement the proposals was introduced to the House of Commons in January 2011, and was the subject of a report by the Health Select Committee in October. Responding to criticism, the government published "Healthy Lives, Healthy People: Update and way forward" in July. The Health and Social Care Act gained royal assent in March 2012, with all elements of the new system to be operative by April 2013.
The Act established Public Health England as an executive body accountable to the Secretary of State for Health. It took over public health activity from the department and from the regional strategic health authorities (which were abolished), and all activities of the Health Protection Agency, the National Treatment Agency for Substance Misuse, the Public Health Observatories, the cancer registries, the National Cancer Intelligence Network, and the UK National Screening Committee together with its screening programmes.
The Department of Health and Social Care set out PHE's remit and priorities in a letter to its chief executive. The last of such letters, published in July 2021, included tasks to implement the transition to the UK Health Security Agency and the Office for Health Improvement and Disparities.
PHE's mission was "to protect and improve the nation's health and to address inequalities". It employed approximately 5,000 staff (full-time equivalent), who were mostly scientists, researchers and public health professionals. It announced plans to move its headquarters and 2,750 staff to Harlow on a former GlaxoSmithKline site in 2017.
PHE laboratories provided an extensive range of microbiological diagnostic tests.
Hub AI
Public Health England AI simulator
(@Public Health England_simulator)
Public Health England
Public Health England (PHE) was an executive agency of the Department of Health and Social Care in England which began operating on 1 April 2013 to protect and improve health and wellbeing and reduce health inequalities. Its formation came as a result of the reorganisation of the National Health Service (NHS) in England outlined in the Health and Social Care Act 2012. It took on the role of the Health Protection Agency, the National Treatment Agency for Substance Misuse and a number of other health bodies. It was an executive agency of the Department of Health and Social Care, and a distinct delivery organisation with operational autonomy.
On 29 March 2021, the UK Government announced that PHE would be disbanded and that its public health functions would be transferred, in proposals to reform public health structures. From 1 October 2021, PHE's health protection functions were formally transferred into the UK Health Security Agency (UKHSA), while its health improvement functions were transferred to the Office for Health Improvement and Disparities (DHSC), NHS England, and NHS Digital.
Proposals for reorganising the National Health Service were published in the early months of the Cameron–Clegg coalition, in a July 2010 white paper from the Department of Health (under Andrew Lansley) titled "Equity and excellence: Liberating the NHS". This was followed by a more detailed paper "Healthy Lives, Healthy People: Our strategy for public health in England" in November.
The bill to implement the proposals was introduced to the House of Commons in January 2011, and was the subject of a report by the Health Select Committee in October. Responding to criticism, the government published "Healthy Lives, Healthy People: Update and way forward" in July. The Health and Social Care Act gained royal assent in March 2012, with all elements of the new system to be operative by April 2013.
The Act established Public Health England as an executive body accountable to the Secretary of State for Health. It took over public health activity from the department and from the regional strategic health authorities (which were abolished), and all activities of the Health Protection Agency, the National Treatment Agency for Substance Misuse, the Public Health Observatories, the cancer registries, the National Cancer Intelligence Network, and the UK National Screening Committee together with its screening programmes.
The Department of Health and Social Care set out PHE's remit and priorities in a letter to its chief executive. The last of such letters, published in July 2021, included tasks to implement the transition to the UK Health Security Agency and the Office for Health Improvement and Disparities.
PHE's mission was "to protect and improve the nation's health and to address inequalities". It employed approximately 5,000 staff (full-time equivalent), who were mostly scientists, researchers and public health professionals. It announced plans to move its headquarters and 2,750 staff to Harlow on a former GlaxoSmithKline site in 2017.
PHE laboratories provided an extensive range of microbiological diagnostic tests.